Correlation Between Accuray Incorporated and Bone Biologics

Can any of the company-specific risk be diversified away by investing in both Accuray Incorporated and Bone Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Accuray Incorporated and Bone Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Accuray Incorporated and Bone Biologics Corp, you can compare the effects of market volatilities on Accuray Incorporated and Bone Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Accuray Incorporated with a short position of Bone Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Accuray Incorporated and Bone Biologics.

Diversification Opportunities for Accuray Incorporated and Bone Biologics

-0.34

Correlation Coefficient

Accuray Incorporated  Bone Biologics

Very good diversification

The 3 months correlation between Accuray and Bone is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding Accuray Incorporated and Bone Biologics Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bone Biologics Corp and Accuray Incorporated is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Accuray Incorporated are associated (or correlated) with Bone Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bone Biologics Corp has no effect on the direction of Accuray Incorporated i.e., Accuray Incorporated and Bone Biologics go up and down completely randomly.

Pair Corralation between Accuray Incorporated and Bone Biologics

Given the investment horizon of 90 days Accuray Incorporated is expected to generate 0.46 times more return on investment than Bone Biologics. However, Accuray Incorporated is 2.19 times less risky than Bone Biologics. It trades about 0.0 of its potential returns per unit of risk. Bone Biologics Corp is currently generating about -0.01 per unit of risk. If you would invest  278.00  in Accuray Incorporated on October 5, 2024 and sell it today you would lose (80.00) from holding Accuray Incorporated or give up 28.78% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Accuray Incorporated  vs.  Bone Biologics Corp

Accuray Incorporated

Risk-Adjusted Performance

3 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Accuray Incorporated are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Accuray Incorporated may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Bone Biologics Corp

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Bone Biologics Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's essential indicators remain nearly stable which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Pair Trading with Accuray Incorporated and Bone Biologics

The main advantage of trading using opposite Accuray Incorporated and Bone Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Accuray Incorporated position performs unexpectedly, Bone Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bone Biologics will offset losses from the drop in Bone Biologics' long position.

The idea behind Accuray Incorporated and Bone Biologics Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.